print-logo
Logo
  • Who we are Arrow Down
    • About us
    • Our purpose & values
    • Our team
    • News & events
  • What we do Arrow Down
    • Overview
    • Lifecycle Management
    • Health Policy
    • Market Access
    • Medical Affairs
    • Marketing
    • Commercial Models
    • Customer & Market Insights
  • Insights Arrow Down
    • Publications
    • Project cases
  • Careers Arrow Down
    • Why join us
    • Open positions
    • Career paths
    • FAQ
  • Contact
  • |
  • Search Icon
  • Search
Back to Publications
  • linkedin_icon
  • twitter_icon
  • mail_icon
  • print_icon

Achieving patient centricity: 4 key lessons from orphan disease companies

Orphan drugs – leading the way in patient centricity

The need to increase patient centricity in pharma is currently a hot topic in the industry, but in the orphan drug / rare disease space it has been a reality for many years.

Read the latest article from Executive Insight and learn the 4 key lessons that are crucial for true patient engagement!

Contact our experts

Meike Wenzel

Meike Wenzel

Partner

mail_icon linkedin_icon
Aleksandar Ruzicic

Aleksandar Ruzicic

Partner

mail_icon linkedin_icon
Wendy van der Lubbe

Wendy van der Lubbe

Principal

mail_icon linkedin_icon

Related Publications

Publication Preview Image

October 10 2016

Orphan drugs – leading the way in patient centricity

Share this page
  • linkedin_icon
  • twitter_icon
  • mail_icon
  • print_icon

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.

OK
arrow_up

How can we help?

Contact us

Our offices

Careers

Footer Logo
  • Who we are
  • What we do
  • Insights
  • Careers
  • Terms of use
  • Privacy policy
  • Imprint

2021 Executive Insight. All rights reserved.